A study was made of the postradiation effect of five indasoline derivatives and proxyfeine on the survival rate and repair of DNA single-strand breaks in E. coli exposed to gamma-irradiation. Some indasoline derivatives (three substances) and proxyfeine added in postradiation medium in nontoxic concentrations decreased the survival rate of radioresistant strains WP2 hcr+, Hr30 and Hs30, but do not influence survival rate of radiosensitive mutant Bs-1. These substances inhibit the repair of DNA single-strand breaks in E. coli WP2 hcr+. Substances, which do not inhibit the survival rate of radioresistant strains, do not inhibit the repair of breaks. Proxyfeine in non-toxic concentrations in non-irradiated cells induces DNA degradation. Indazoline derivatives do not induce DNA degradation. Data presented suggest that indasolines are new class inhibitors of DNA repair. It is possible that proxyfeine is too an inhibitor of DNA repair.

Download full-text PDF

Source

Publication Analysis

Top Keywords

survival rate
16
indasoline derivatives
8
repair dna
8
dna single-strand
8
single-strand breaks
8
breaks coli
8
rate radioresistant
8
radioresistant strains
8
wp2 hcr+
8
substances inhibit
8

Similar Publications

Background And Aim: Coronary artery bypass grafting (CABG) is a key treatment for coronary artery disease, but accurately predicting patient survival after the procedure presents significant challenges. This study aimed to systematically review articles using machine learning techniques to predict patient survival rates and identify factors affecting these rates after CABG surgery.

Methods: From January 1, 2015, to January 20, 2024, a comprehensive literature search was conducted across PubMed, Scopus, IEEE Xplore, and Web of Science.

View Article and Find Full Text PDF

Introduction: The prognostic impact of human leukocyte antigen-E (HLA-E) expression and the proportion of natural killer (NK) cells in esophageal squamous cell carcinoma (ESCC) was investigated.

Methods: This study retrospectively evaluated 397 ESCC patients across two centers. The cumulative incidence of recurrence (CIR) and the incidence of tumor-related death (CID) were analyzed in various groups.

View Article and Find Full Text PDF

Background: Abnormal thyroid hormone levels may occur in critical illness, which may have an interactive relationship with inflammatory reaction. At present, the relationship between triiodothyronine (T3)/thyroxine (T4) ratio and inflammatory indicators and all-cause mortality of stroke survivors is still unclear.

Methods: We obtained the relevant data of the respondents from 2007 to 2012 through the National Health and Nutrition Examination Survey (NHANES) database for statistical analysis.

View Article and Find Full Text PDF

Characteristics and outcomes of patients with LAM receiving sirolimus in France based on real-life data.

Front Med (Lausanne)

January 2025

Department of Respiratory Medicine, Reference Centre for Rare Pulmonary Diseases, APHP, Hôpital Avicenne, INSERM U 1272, Université Sorbonne Paris-Nord, Bobigny, France.

LAM is a rare multi-cystic lung disease for which treatment with sirolimus is indicated in cases of moderate or severe lung disease or declining lung function. The aim of this study was to describe patients treated with sirolimus for LAM and their outcomes. This retrospective observational study was based on data from the French national health insurance data system (SNDS).

View Article and Find Full Text PDF

Background And Objective: Oral bacteria can translocate to the intestine, and their colonization efficiency is influenced by the gastrointestinal tract pH. Understanding how oral bacteria resist acidic environments is crucial for elucidating their role in gut health and disease.

Methods: To investigate the mechanisms of acid resistance in oral bacteria, an in vitro gastrointestinal tract Dynamic pH Model was established.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!